Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
8.73M
-
Shares change
-
-1.57M
-
Total reported value, excl. options
-
$18.3M
-
Value change
-
-$3.51M
-
Put/Call ratio
-
2.14
-
Number of buys
-
16
-
Number of sells
-
-23
-
Price
-
$2.10
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q4 2022
52 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q4 2022.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.73M shares
of 100M outstanding shares and own 8.69% of the company stock.
Largest 10 shareholders include Long Focus Capital Management, LLC (2.68M shares), CREDIT SUISSE AG/ (1.44M shares), PRINCIPAL FINANCIAL GROUP INC (1.33M shares), MILLENNIUM MANAGEMENT LLC (680K shares), BAILLIE GIFFORD & CO (600K shares), Capital International Investors (449K shares), Capital World Investors (250K shares), D. E. Shaw & Co., Inc. (227K shares), MACQUARIE GROUP LTD (227K shares), and JANE STREET GROUP, LLC (211K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.